Company: BSTZ
Filing Date: 2025-03-07
Form Type: N-CSR
Source: 0001193125-25-049659
Chunk: 43

Company: BlackRock Science & Technology Term Trust
Filing Date: 2025-03-07
Form: N-CSR
Chunk 43
---
 writtenOptions written at value        | $—                 | $—              |      $4,114,542 | $—                               | $—                    | $—             | $4,114,542 |

60 2024 BlackRock Annual Report to Shareholders

Schedule of Investments (continued) December 31, 2024 BlackRock Enhanced Global Dividend Trust (BOE)

For the period ended December 31, 2024, the effect of derivative financial instruments in the Statements of Operations was as follows:

|                                                          | CommodityContracts | CreditContracts | EquityContracts | ForeignCurrencyExchangeContracts | InterestRateContracts | OtherContracts |         Total |
| Net Realized Gain (Loss) from:                           |                    |                 |                 |                                  |                       |                |               |
| Options purchased(a)                                     | $—                 | $—              |        $(7,534) | $—                               | $—                    | $—             |      $(7,534) |
| Options written                                          | —                  | —               |     -15,973,502 | —                                | —                     | —              |   -15,973,502 |
|                                                          | $—                 | $—              |   $(15,981,036) | $—                               | $—                    | $—             | $(15,981,036) |
| Net Change in Unrealized Appreciation (Depreciation) on: |                    |                 |                 |                                  |                       |                |               |
| Options written                                          | $—                 | $—              |      $7,740,032 | $—                               | $—                    | $—             |    $7,740,032 |

| (a) | Options purchased are included in net realized gain (loss) from investments — 
 unaffiliated.                                                                 |

Average Quarterly Balances of Outstanding Derivative Financial Instruments

| Options:                                    |           |
| Average value of option contracts purchased |     $—(a) |
| Average value of option contracts written   | 8,180,000 |

| (a) | Derivative financial instrument not held at any quarter-end. The risk exposure table serves as an 
 indicator of activity during the period.                                                          |

For more information about the Trust’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements. Derivative Financial Instruments — Offsetting as of Period End The Trust’s derivative assets and liabilities (by type) were as follows:

|                                                                                     | Assets | Liabilities |